Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Hepatocellular 5Small Cell Lung Carcinoma 4Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Liver Neoplasms 2Treatment-Refractory Solid Tumors 1Rare Tumour 1Prostatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Extensive Stage Lung Small Cell Cancer 1Colorectal Neoplasms 1Carcinoma, Small Cell 1Carcinoma, Renal Cell 1

Interventions

atezolizumab 1Penfluridol 1PM 01183 1Etoposide 1EC regimen 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Carcinoma, Small Cell × atezolizumab × Clear all
NCT07625644 2026-06-04

Evaluate BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer

SystImmune Inc.

Phase 3 Not yet recruiting
550 enrolled
Thoracic

Lung Neoplasms, Carcinoma, Small Cell, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡